Reham Helwa

Reham Helwa

Auto-generated profile, based on publicly available information

Reham Helwa

Molecular Cancer Biology Group, Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2009 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
SDSusanne Dihlmann
Susanne Dihlmann
RHReham Helwa
Reham Helwa
SMStephan Macher‐Goeppinger
Stephan Macher‐Goeppinger
JWJurgen Weitz
Jurgen Weitz
KBKarsten Brand
Karsten Brand

1 September 2016 in Experimental Neurology
Verified
Journal Article
Closed access
Amal Kamal Abdel-AzizAmal Kamal Abdel-Aziz
Amal Kamal Abdel-Aziz
EMEman M. Mantawy
Eman M. Mantawy
RSRiham Soliman Said
Riham Soliman Said
RHReham Helwa
Reham Helwa

21 August 2010 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
RHReham Helwa
Reham Helwa
JHJörg D. Hoheisel
Jörg D. Hoheisel
Determination of the sequence of the human genome and knowledge of the genetic code have allowed rapid progress in the identification of mammalian proteins. However, far less is known about the molecular mechanisms that control expression of human genes and about the variations in gene expression that underlie many pathological states, including cancer. This is caused in part by lack of information about the binding specificities of DNA-binding proteins and particularly regulative important molecules such as transcription factors. It is consequently crucial to develop new technologies or improve existing ones for the analysis of DNA–protein interaction in order to identify and characterise DNA response elements and the related transcription factors or other DNA-binding proteins. The techniques that are currently available vary with respect to the type of result that can be expected from the assay: a mere qualitative demonstration of binding; the identification of response element sequences at high throughput; or a quantitative characterisation of affinities. This article gives an overview of early and recent methodologies applied to such ends.

20 March 2016 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
NENadia Mohamed El-Guendy
Nadia Mohamed El-Guendy
RHReham Helwa
Reham Helwa
MEMedhat Salah El-Halawany
Medhat Salah El-Halawany
SAShimaa Abdel Rahman Ali
Shimaa Abdel Rahman Ali
MTMarwa Tantawy
Marwa Tantawy
AAAbdel-Hady Ali Abdel-Wahab
Abdel-Hady Ali Abdel-Wahab
Background: MicroRNAs (miRNAs) have been repeatedly shown to play important roles in liver pathologies, including hepatitis, liver cirrhosis, and liver cancer. Egypt has the highest hepatitis C virus (HCV) infection rate worldwide, predominantly involving genotype-4. Objectives: In this study, we attempted to characterize the miRNA profile of the poorly studied genotype 4 of HCV in chronically infected Egyptian patients to obtain a better understanding of the disease and its complications and help in the design of better management protocols. Patients and Methods: We analyzed the expression levels of a selected panel of 94 miRNAs in fresh liver biopsies collected from 50 Egyptian patients diagnosed with chronic HCV infection using quantitative real-time polymerase chain reaction (PCR) assay. Non-parametric tests were used to analyze the expression level of each miRNA and association with the clinicopathological features of enrolled patients in this study. Results: Our results revealed differential expression levels of the analyzed miRNAs compared to the normal controls. Twenty-seven miRNAs (including miR-105, miR-147, miR-149-3p, and miR-196b) showed up-regulation, while 17 miRNAs (including miR-21, miR-122, miR-199a-3p, and miR-223) showed down-regulation. An inverse correlation was observed between levels of miR-95, miR-130a, and miR-142-5p with the blood albumin level. Increased expression levels of seven miRNAs (miR-29c, miR-30c, miR-126, miR-145, miR-199a, miR-199a-3p, and miR-222) were observed with severe chronic hepatic inflammation. Several deregulated miRNAs found in this study have been previously linked to chronic liver inflammation and the risk of hepatocellular carcinoma (HCC) development. Conclusions: The identified expression profiles of some examined miRNAs might offer important points to consider for the treatment of naive patients and the management of chronically infected HCV patients in Egypt and around the world. Keywords: Hepatitis C; MicroRNAs; Genotype-4; Real-Time Polymerase Chain Reaction; Liver Cirrhosis

14 March 2017 in Cellular Oncology
Verified
Journal Article
Closed access
PDF file
RHReham Helwa
Reham Helwa
AHAnette Heller
Anette Heller
SKStian Knappskog
Stian Knappskog
ABAndrea S. Bauer
Andrea S. Bauer

9 May 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
ALAsmaa A. El Leithy
Asmaa A. El Leithy
RHReham Helwa
Reham Helwa
MAMagda M. Assem
Magda M. Assem
NHNagwa H. A. Hassan
Nagwa H. A. Hassan